Jon Ramm-Pettersen

Jon Ramm-Pettersen

Auto-generated profile, based on publicly available information

Jon Ramm-Pettersen

Department of Neurosurgery, Oslo University Hospital, 0027 Oslo, Norway

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2011 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
JRJon Ramm-Pettersen
Jon Ramm-Pettersen
JBJon Berg-Johnsen
Jon Berg-Johnsen
PHPer Kristian Hol
Per Kristian Hol
SRSumit Roy
Sumit Roy
JBJens Bollerslev
Jens Bollerslev
EHEirik Helseth
Eirik Helseth
Background During trans-sphenoidal microsurgical resection of pituitary adenomas, the extent of resection may be difficult to assess, especially when extensive suprasellar and parasellar growth has occurred. In this prospective study, we investigated whether intra-operative magnetic resonance imaging (iMRI) can facilitate tumour resection. Methods Twenty patients with macroadenomas, (16 non-functioning, three growth-hormone secreting and one pharmaco-resistant prolactinoma) were selected for surgery in the iMRI. The mean tumour diameter was 27 mm (range 11–41). The mean parasellar grade, according to the Knosp classification, was 2.3. Pre-operative coronal and sagittal T1-weighted and T2-weighted images were obtained. The trans-sphenoidal tumour resection was performed at the edge of the tunnel of a Signa SP 0.5-Tesla MRI. The surgeon aimed at a radical tumour resection that was followed by a peri-operative MRI scan. When a residual tumour was visualised and deemed resectable, an extended resection was performed, followed by another MRI scan. This procedure was repeated until the imaging results were satisfactory. In all patients, we were able to obtain images to assess the extent of resection and to classify the resection as either total or subtotal. Results After primary resection, eight out of 20 cases were classified as total resections. A second resection was performed in 11 of 12 cases classified as subtotal resections, and in four of these, total resection was achieved. A third resection was performed in three of the remaining seven cases with subtotal resections, but we did not achieve total resection in any of these cases. Therefore, the use of iMRI increased the number of patients with total resection from 8/20 (40%) to 12/20 (60%). The only observed complication was a transient spinal fluid leakage. Conclusion Intra-operative MRI during trans-sphenoidal microsurgery is useful in selected patients for a safe and more complete resection.

14 April 2009 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
JRJon Ramm-Pettersen
Jon Ramm-Pettersen
GBGregor Bachmann-Harildstad
Gregor Bachmann-Harildstad
TMTorstein Meling
Torstein Meling
PHPer Kristian Hol
Per Kristian Hol
JBJon Berg-Johnsen
Jon Berg-Johnsen
Introduction: Endoscopic endonasal skull base surgery provides advantages including improved visualization, no need for brain retraction, and low morbidity. Patients with complex skull base lesions were selected for surgery in a multidisciplinary setting that involved neurosurgery, otorhinolaryngology, and interventional radiology. Postoperative complications and the duration of hospitalization were registered. Material and Methods: Surgery was performed in a dedicated operating suite with neuronavigation and 3 T intraoperative MRI. During the last year, we have operated on 22 patients in this setting with the following: nonproducing pituitary adenomas in 10 patients, clivus chordomas in 2, Wegener's granulomatosis in 2, recurrent CSF leak in 2, olfactory meningeoma in 1, schneiderian papilloma in 1, fibrous dysplasia in 1, petrous apex epidermoid in 1, meningoencephalocele in 1, and mucocele in 1. Results: No postoperative hematomas or infections were recorded, and none of the patients experienced deterioration of vision. In 2 patients, there was a postoperative CSF leak (9%). One of these had another surgery, and the other resolved with lumbar drainage. Postoperative hospitalization varied between 0 and 18 days, with a mean of 4.2 days and a median of 3 days. The patients who had CSF leak were both hospitalized, 1 for 18 days and the other for 12. By excluding the 2 patients with complications, the mean postoperative hospitalization was reduced to 3.1 days and the median to 2.5 days. Conclusion: Endoscopic endonasal surgery is a safe procedure for a variety of lesions at the skull base. The complications are mainly related to problems with watertight closure and skull base reconstruction, which constitute the main obstacles to further refinement of this surgery. The postoperative hospital stay is short, and the morbidity is low after endoscopic endonasal surgery.

1 April 2013 in Endocrine Abstracts
Verified
Journal Article
Closed access
AHAnsgar Heck
Ansgar Heck
OCOlivera Casar-Borota
Olivera Casar-Borota
JRJon Ramm-Pettersen
Jon Ramm-Pettersen
SSStefan Schulz
Stefan Schulz
JBJens Bollerslev
Jens Bollerslev
Introduction: The effect of conventional somatostatin agonists (SA) on somatotroph pituitary adenomas is primarily mediated by somatostatin receptors (sstr) subtype 2. Sstr expression has been proposed as a prognostic marker for response to medical therapy. Earlier studies have shown lower sstr2a expression in SA treated adenomas, but selection bias could not be excluded. Objective: To assess the effect of SA on the immunohistochemical expression of sstr2a, 3 and 5. Patients and methods: Histological specimens from 78 somatotroph adenomas from patients operated for acromegaly at Oslo University Hospital, Rikshospitalet between 2000 and 2010 were evaluated. After exclusion of specimens without representative tumour tissue and from patients with pretreatment other than SA, 65 patients were included in the study. 28 of these were pretreated with SA (SA-group), 37 were operated directly (directsurgery-group; DS). Immunohistochemical staining was performed with novel monoclonal anti-SSTR2A (UMB-1), anti-SSTR3 (UMB-5), and anti-SSTR5 (UMB-4) antibodies. The adenomas were scored into 12 categories by the IRS-score. A subgroup of the 26 patients was earlier included in a randomised trial comparing direct surgery with surgery performed after SA treatment. Subgroup analyses were performed on this group. Results: Immunohistochemical score for sstr2a in the pretreated patients (SA-group) was significantly lower than in patients operated directly (DS-group) (P=0.002). Subgroup analysis in the randomised patients confirmed this finding. Scores for sstr3 and sstr 5 were not significantly different between groups. There was no significant difference in sstr 3 and 5 score between the treatment groups. Conclusion: Sstr2 is down regulated by SA treatment. Subgroup analyses in the randomised cohort excluded selection bias concerning pretreatment. There is no major effect of SA treatment on sstr3 and sstr5.